Translational Engineering in Cancer The Translational Engineering in Cancer (TEC) Program brings together 25 faculty, representing 12 departments at Dartmouth?s Geisel School of Medicine (Geisel), its Thayer School of Engineering and its Guarini School of Graduate and Advanced Studies; and the Dartmouth-Hitchcock Medical Center (DH), with research interests relevant to three central TEC Program themes: 1) Surgical image-guidance, 2) Radiation monitoring and guidance, and 3) Cellular/molecular detection and contrast. The shared goals of the TEC Program are to: 1) Utilize biophysical and bioengineering approaches to develop and translate new imaging, engineering and treatment technologies that improve the care of cancer patients; 2) Impact cancer detection, diagnosis, and treatment ? nationally, regionally, and within the NCCC catchment area especially for malignancies of the brain/CNS, breast, skin, head & neck, pancreas and prostate ? by providing access to novel imaging modalities, interventional protocols enhanced by imaging and image-guidance, and dosimetry technology for assessing radiation treatments; and 3) Translate laboratory results into clinical studies via development of novel technologies that fuel academic-industrial partnerships, as well as start-up ventures and other industry relationships, to drive Dartmouth-generated technology towards clinical dissemination with the goal of changing and improving practice. Peer-reviewed cancer-related research direct cost support currently totals $6.4M, with NCI funding representing 53% ($3.4M) and total direct costs summing to $6.5M. Thirteen (13) TEC Program Members currently have a total of 17 CCSG-defined R01-equivalent awards. Using the same definition of cancer-related direct costs in 2014 (i.e., excluding all indirects as well as training and administrative direct costs), peer-reviewed cancer-related research direct costs ($6.4M) are 44% less compared to 2014 ($11.3M), but 60% of the 2014 total ($7.0M) was attributable to one large BARDA award. Since 2015, the Program has 306 cancer-related publications, 51% (157) intra-programmatic, 25% (76) inter- programmatic, 51% (156) with investigators from other institutions, and 11% (28) in high impact journals (i.e., impact factor >8), which are uncommon in engineering publications. Compared to 2014, intra-programmatic remains high (51% and 60%), and inter-programmatic has increased, to 25% from 20%. During the proposed funding period, TEC will leverage new Center for Imaging Medicine facilities in the Williamson building and the significant expansion of Dartmouth?s Thayer School of Engineering Faculty and co-location with Computer Science, as part of a major capital campaign recently announced to grow significantly its imaging and image- guidance research base in surgical oncology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-42
Application #
10165520
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
42
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Shee, Kevin; Yang, Wei; Hinds, John W et al. (2018) Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med 215:895-910
Gareen, Ilana F; Black, William C; Tosteson, Tor D et al. (2018) Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings. Med Care 56:403-409
Kuklinski, Lawrence F; Yan, Shaofeng; Li, Zhongze et al. (2018) VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival. Cancer Immunol Immunother 67:1113-1121
Ji, Xiangming; Niu, Xinnan; Qian, Jun et al. (2018) A Phenome-Wide Association Study Uncovers a Role for Autoimmunity in the Development of Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 58:777-779
Miles, Randy; Wan, Fei; Onega, Tracy L et al. (2018) Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt) 27:748-754
Soneji, Samir S; Sung, Hai-Yen; Primack, Brian A et al. (2018) Quantifying population-level health benefits and harms of e-cigarette use in the United States. PLoS One 13:e0193328
Durand, Marie-Anne; Yen, Renata West; O'Malley, A James et al. (2018) What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata. BMC Public Health 18:241
Courtney, Andrea L; Rapuano, Kristina M; Sargent, James D et al. (2018) Brain Reward Responses Are Behaviorally Relevant: The Authors Respond. J Stud Alcohol Drugs 79:41-42
Tosteson, Anna N A; Yang, Qian; Nelson, Heidi D et al. (2018) Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat 167:195-203
Molodtsov, Aleksey; Turk, Mary Jo (2018) Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity. Front Immunol 9:2810

Showing the most recent 10 out of 1911 publications